Compare AFC-HD AMS Life Science Co., Ltd. with Similar Stocks
Dashboard
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Operating profit has grown by an annual rate 18.20% of over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Healthy long term growth as Net Sales has grown by an annual rate of 15.33%
3
Negative results in May 25
4
With ROCE of 8.10%, it has a very attractive valuation with a 0.91 Enterprise value to Capital Employed
5
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
6.35%
0%
6.35%
6 Months
7.38%
0%
7.38%
1 Year
-3.06%
0%
-3.06%
2 Years
13.99%
0%
13.99%
3 Years
17.0%
0%
17.0%
4 Years
-9.3%
0%
-9.3%
5 Years
28.7%
0%
28.7%
AFC-HD AMS Life Science Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
15.33%
EBIT Growth (5y)
18.20%
EBIT to Interest (avg)
29.74
Debt to EBITDA (avg)
3.17
Net Debt to Equity (avg)
0.85
Sales to Capital Employed (avg)
0.81
Tax Ratio
29.45%
Dividend Payout Ratio
33.02%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.60%
ROE (avg)
9.22%
Valuation key factors
Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
0.84
EV to EBIT
11.27
EV to EBITDA
7.19
EV to Capital Employed
0.91
EV to Sales
0.76
PEG Ratio
0.73
Dividend Yield
NA
ROCE (Latest)
8.10%
ROE (Latest)
10.24%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Nov'25 - YoY
Nov'25
Nov'24
Change(%)
Net Sales
8,547.60
8,189.90
4.37%
Operating Profit (PBDIT) excl Other Income
1,112.90
984.10
13.09%
Interest
54.00
37.60
43.62%
Exceptional Items
23.60
-1.10
2,245.45%
Consolidate Net Profit
519.70
465.40
11.67%
Operating Profit Margin (Excl OI)
90.30%
79.50%
1.08%
USD in Million.
Net Sales
YoY Growth in quarter ended Nov 2025 is 4.37% vs 20.68% in Nov 2024
Consolidated Net Profit
YoY Growth in quarter ended Nov 2025 is 11.67% vs 45.71% in Nov 2024
Annual Results Snapshot (Consolidated) - Aug'25
Aug'25
Aug'24
Change(%)
Net Sales
32,655.00
30,185.50
8.18%
Operating Profit (PBDIT) excl Other Income
3,777.30
3,011.80
25.42%
Interest
201.20
101.30
98.62%
Exceptional Items
-218.70
-33.00
-562.73%
Consolidate Net Profit
1,468.80
1,245.40
17.94%
Operating Profit Margin (Excl OI)
72.90%
63.80%
0.91%
USD in Million.
Net Sales
YoY Growth in year ended Aug 2025 is 8.18% vs 18.01% in Aug 2024
Consolidated Net Profit
YoY Growth in year ended Aug 2025 is 17.94% vs 12.54% in Aug 2024
About AFC-HD AMS Life Science Co., Ltd. 
AFC-HD AMS Life Science Co., Ltd.
FMCG
No Details Available.
Company Coordinates 
No Company Details Available






